Med Life S.A. (BVB:M)

Market Cap	6.03B +98.2%
Revenue (ttm)	3.25B +14.2%
Net Income	7.67M -68.0%
EPS	0.01 -68.4%
Shares Out	530.82M
PE Ratio	785.96
Forward PE	45.44
Dividend	n/a
Ex-Dividend Date	n/a

Volume	163,575
Open	11.28
Previous Close	11.28
Day's Range	11.16 - 11.36
52-Week Range	6.52 - 14.46
Beta	0.41
Analysts	Hold
Price Target	9.97 (-12.24%)
Earnings Date	May 29, 2026

About Med Life

Med Life S.A., a private healthcare provider, provides integrated medical services through its clinics and hospitals in Romania. The company offers outpatient units and diagnostic imaging services; consultations with general practitioners and specialists; diagnostic imaging tests; day hospitalization services; hospitalization and surgical treatment services; medical and surgical specialties; maternal and child health dedicated services; and stem cell bank. It also provides laboratory services, such as biochemistry, pathological anatomy, molecul...

• Industry: Health Services
• Founded: 1996
• Employees: 6,962
• Stock Exchange: Bucharest Stock Exchange
• Ticker Symbol: M

Financial Performance

In 2025, Med Life's revenue was 3.17 billion, an increase of 16.86% compared to the previous year's 2.72 billion. Earnings were 11.27 million, a decrease of -55.00%.

Analyst Summary

According to 4 analysts, the average rating for M stock is "Hold." The 12-month stock price target is lei 9.97, which is a decrease of -12.24% from the latest price.

Price Target

lei 9.97

(-12.24% downside)

Analyst Consensus: Hold